216 related articles for article (PubMed ID: 11504823)
21. Orphanin FQ/nociceptin modulates glutamate- and kainic acid-induced currents in acutely isolated rat spinal dorsal horn neurons.
Shu YS; Zhao ZQ; Li MY; Zhou GM
Neuropeptides; 1998 Dec; 32(6):567-71. PubMed ID: 9920456
[TBL] [Abstract][Full Text] [Related]
22. Orphanin FQ in the mediobasal hypothalamus facilitates sexual receptivity through the deactivation of medial preoptic nucleus mu-opioid receptors.
Sanathara NM; Moraes J; Kanjiya S; Sinchak K
Horm Behav; 2011 Nov; 60(5):540-8. PubMed ID: 21872598
[TBL] [Abstract][Full Text] [Related]
23. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.
Norton CS; Neal CR; Kumar S; Akil H; Watson SJ
J Comp Neurol; 2002 Mar; 444(4):358-68. PubMed ID: 11891648
[TBL] [Abstract][Full Text] [Related]
25. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
Lutfy K; Maidment NT
Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
[TBL] [Abstract][Full Text] [Related]
26. Prolonged ovarian sex steroid treatment of male rats produces antinociception: identification of sex-based divergent analgesic mechanisms.
Liu NJ; Gintzler AR
Pain; 2000 Mar; 85(1-2):273-81. PubMed ID: 10692628
[TBL] [Abstract][Full Text] [Related]
27. Nociceptin/orphanin FQ increases ANP secretion in neonatal cardiac myocytes.
Kim KW; Chung YJ; Han JH; Woo RS; Park EY; Seul KH; Kim SZ; Cho KW; Kim SH
Life Sci; 2002 Jan; 70(9):1065-74. PubMed ID: 11860154
[TBL] [Abstract][Full Text] [Related]
28. Sex-/ovarian steroid-dependent release of endomorphin 2 from spinal cord.
Gupta DS; von Gizycki H; Gintzler AR
J Pharmacol Exp Ther; 2007 May; 321(2):635-41. PubMed ID: 17308039
[TBL] [Abstract][Full Text] [Related]
29. Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition.
Liu NJ; Schnell SA; Schulz S; Wessendorf MW; Gintzler AR
J Pharmacol Exp Ther; 2011 Feb; 336(2):328-35. PubMed ID: 20974701
[TBL] [Abstract][Full Text] [Related]
30. Relationship of spinal dynorphin neurons to delta-opioid receptors and estrogen receptor alpha: anatomical basis for ovarian sex steroid opioid antinociception.
Gintzler AR; Schnell SA; Gupta DS; Liu NJ; Wessendorf MW
J Pharmacol Exp Ther; 2008 Sep; 326(3):725-31. PubMed ID: 18541716
[TBL] [Abstract][Full Text] [Related]
31. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord.
Inoue M; Shimohira I; Yoshida A; Zimmer A; Takeshima H; Sakurada T; Ueda H
J Pharmacol Exp Ther; 1999 Oct; 291(1):308-13. PubMed ID: 10490918
[TBL] [Abstract][Full Text] [Related]
32. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
Wang JL; Zhu CB; Cao XD; Wu GC
Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
[TBL] [Abstract][Full Text] [Related]
33. Dynorphin A inhibits nociceptin-converting enzyme from the rat spinal cord.
Suder P; Wade D; Łegowska A; Kotlińska J; Rolka K; Silberring J
Biochem Biophys Res Commun; 2001 Oct; 287(4):927-31. PubMed ID: 11573954
[TBL] [Abstract][Full Text] [Related]
34. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
[TBL] [Abstract][Full Text] [Related]
35. Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat.
Lutfy K; Sharza SA; Maidment NT
Neuroreport; 1999 Jan; 10(1):103-6. PubMed ID: 10094142
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
Arduin M; Spagnolo B; Calò G; Guerrini R; Carrà G; Fischetti C; Trapella C; Marzola E; McDonald J; Lambert DG; Regoli D; Salvadori S
Bioorg Med Chem; 2007 Jul; 15(13):4434-43. PubMed ID: 17490886
[TBL] [Abstract][Full Text] [Related]
37. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities.
Reinscheid RK; Higelin J; Henningsen RA; Monsma FJ; Civelli O
J Biol Chem; 1998 Jan; 273(3):1490-5. PubMed ID: 9430687
[TBL] [Abstract][Full Text] [Related]
38. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
39. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
[TBL] [Abstract][Full Text] [Related]
40. Orphanin FQ-ORL-1 regulation of reproduction and reproductive behavior in the female.
Sinchak K; Dalhousay L; Sanathara N
Vitam Horm; 2015; 97():187-221. PubMed ID: 25677773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
